Question: Can Depo-Provera legal compensation cases still be filed after a meningioma warning was added in December 2025 to the Depo-Provera drug label? Short Answer: Yes, new Depo-Provera lawsuits can be filed if you received a Depo-Provera injection before December 2025, and were diagnosed with meningioma any time after those … [Read more...]
Semaglutide Deep Vein Thrombosis Case Information: 2026 Medical Journal Article
A 2026 medical journal article, which presented some semaglutide deep vein thrombosis case information, is of interest to us because Ozempic, Wegovy, and Rybelsus — three relatively new semaglutide-containing drugs — have been associated with a significantly increased risk of blood clots. We have been investigating Ozempic, Wegovy, and Rybelsus … [Read more...]
Pericardial Mesothelioma: Diagnostic and Therapeutic Management, a Population-Based Study in Italy
Pericardial mesothelioma (PM) is an extremely rare tumour for which only case reports, small case series, and case reviews have been published. This is a large population-based study on PM in Italy using data from the Italian National Mesothelioma Registry (Registro Nazionale Mesoteliomi, ReNaM). Information collected includes detailed clinical … [Read more...]
NAION Lawsuits Involving Ozempic and Mounjaro
As we have reported previously, vision loss due to Non-Arteritic Anterior Ischemic Optic Neuropathy (NAION) lawsuits involving Ozempic and Mounjaro are being filed. These NAION lawsuits seek legal compensation for the person suffering from this serious eye side effect injury. Ozempic NAION lawsuits are filed against Novo Nordisk. Mounjaro NAION … [Read more...]
Pleural Mesothelioma Diagnosis for the Pulmonologist: Steps Along the Way
Background/Objectives: Malignant pleural mesothelioma (MPM) is a rare, aggressive tumor with a poor prognosis and complex diagnostic pathways. Pulmonologists often play a central role in its initial recognition and investigation. This narrative review synthesizes the current evidence on [mesothelioma diagnosis], with emphasis on imaging, tissue … [Read more...]
Andexxa Risks Outweigh Its Benefits, Says FDA In December 2025
When AstraZeneca asserted that their recent Andexxa drug recall had to do with “commercial reasons”, we suggested that there was an Andexxa drug safety issue involved, also, in our December 15, 2025, Drug Injury Watch post, "Andexxa Drug Recall December 2025 Due In Part To Safety Issue That Involves Blood Clots". And this December 18, 2025, FDA … [Read more...]
Global burden of lung cancer attributable to occupational asbestos exposure: 1990 to 2021
Background: Asbestos is a well-established occupational carcinogen, with strong evidence linking its exposure to lung cancer. Despite increasing awareness of its health risks, asbestos continues to be used in many countries. We aimed to evaluate the global burden of lung cancer attributable to occupational asbestos exposure and to analyze its … [Read more...]
Wegovy and Ozempic Eye Damage Compensation In Europe, Is US Next?
Drug injury lawsuits seeking compensation for patients with Wegovy and Ozempic eye damage side effects have been filed against the pharmaceutical company Novo Nordisk. These Wegovy and Ozempic eye damage lawsuits have received a boost, it seems, from some recent news out of Europe. From this November 21, 2025, article, "Denmark compensates … [Read more...]
Depo-Provera: Two Risk Factors for Meningioma Identified in 2025
A new 2025 medical study about Depo-Provera (depot medroxyprogesterone acetate) identified two risk factors for meningioma, a side effect associated with Depo-Provera injections. An article in the November 2025 edition of the medical journal JAMA Neurology, “Depot Medroxyprogesterone Acetate and Risk of Meningioma in the US”, which reported the … [Read more...]
A Case of Primary Malignant Peritoneal Mesothelioma
Primary malignant mesothelioma (MPM) is a rare malignancy that arises from the epithelial cells that line visceral cavities. The primary pleural presentation is known as the most commonly seen presentation and is best recognized clinically. Less commonly, mesothelioma can arise from epithelial cells lining other visceral cavities, including the … [Read more...]
- 1
- 2
- 3
- …
- 24
- Next Page »